Candida auris is an emergent fungal pathogen of rising public health concern due to increasing 13 reports of outbreaks in healthcare settings and resistance to multiple classes of antifungal 14 drugs. While distantly related to the more common pathogens C. albicans and C. glabrata, C.
144
related MDR species.
146
As an independent assessment of the genome assembly size and structure, we generated 147 optical maps of the C. auris B8441 and B11221 isolates ( Figure S1) . Consistent with the 148 assemblies of these isolates, the maps had seven linkage groups; nearly all of the genome 149 assemblies were anchored to the optical maps (98.8 % of B8441 and 97.2 % of B11221; Figure 150 S1; Table 1 ). This supports the presence of seven chromosomes in C. auris, consistent with the 151 chromosome number found in previous studies using electrophoretic karyotyping by pulsed-field 152 gel electrophoresis (PFGE) 22 . While the genomes of C. auris are highly syntenic, we found 153 evidence of a few large chromosomal rearrangements between C. auris B8441 and B11221 154 based on comparison of the assemblies and the optical maps (Figures 1, S1) . We confirmed 155 that the junctions of these rearrangements are well supported in each assembly; these regions (Figure 2a ; Table S3 ). We found that the MTLa is present in C. auris B8441 and 6684 188 (clade I), B11243 (clade IV), and C. pseudohaemulonii, spanning 14.9 kb (Figure 2a) . By (Figure 2a) . data was used to guide gene prediction of a1 and a2, and further established that both genes 196 are expressed in B8441 (Figure S2) , supporting the hypothesis that these genes could be 197 functional, and that the MTL locus could be used to classify C. auris isolates. To further 198 characterize the evolution of mating type in the population, we examined the MTL locus using 
205
We examined the conservation of genes involved in meiosis to provide additional support for 206 potential mating in C. auris. We found that many of the key meiotic genes are similarly 207 conserved between C. lusitaniae, C. guilliermondii, C. auris, C. haemulonii, C.
208 duobushaemulonii and C. pseudohaemulonii (Table S3 ). Some genes involved in meiosis in S.
209
cerevisiae appeared absent in these species including the recombinase DMC1 and cofactors 210 (MEI5 and SAE3), synaptonemal-complex proteins (ZIP1 and HOP1), and genes involved in 211 crossover interference (MSH4 and MSH5; Table S3 ). A small number of genes involved in 212 meiosis were present in C. lusitaniae but absent in C. auris, C. haemulonii, C.
213
duobushaemulonii, and C. pseudohaemulonii. In C. auris, the DNA recombination and repair 214 genes RAD55 and RAD57 appear to be absent, however RAD55 is widely absent in the CTG (Table S2) . Based on a concatenated alignment of 1,570 single copy core genes, a well 228 supported maximum likelihood tree placed C. auris, C. haemulonii, C. duobushaemulonii, and 229 C. pseudohaemulonii as a single clade, confirming the close relationship of these species 230 (100% of bootstrap replicates; Figure 3a ). The C. auris clades appear more recently diverged 231 based on short branch lengths within this species. Previous phylogenetic analyses had shown 232 conflicting relationships between C. auris, C. haemulonii, C. duobushaemulonii, and C. 233 pseudohaemulonii 4,5,12,13 . Our phylogenetic analysis strongly supports that C. duobushaemulonii 234 and C. pseudohaemulonii are most closely related to each other, and form a sister group to C.
235
haemulonii, which appeared as the more basally branching species (Figure 3a) . The most 236 8 closely related species to this MDR clade is C. lusitaniae, which is the more basally branching 237 member of this group (Figure 3a) .
239
Gene family expansions supported mechanisms of drug resistance and virulence 240 Gene annotation of the C. auris genomes was performed using RNA-Seq paired-end 241 reads to improve gene structure predictions (Methods). The predicted gene number was highly 242 similar across all C. auris genomes as well as in C. haemulonii, C. duobushaemulonii, and C.
243
pseudohaemulonii. In C. auris, the number of protein-coding genes varied between 5,421 in 244 B8441 and 5,601 in B11243. For C. haemulonii, C. duobushaemulonii, and C. 245 pseudohaemulonii the numbers were very similar, ranging from 5,288 to 5,410 predicted genes 246 (Table 1; Figure S4a ). High representation of core eukaryotic genes provides evidence that 247 these genomes are nearly complete; 96-98% of these conserved genes are found in all (Table S4 ).
263
To characterize changes in gene content that may play a role in the evolution of multidrug- 
296

Conservation of known drug resistance and pathogenesis-associated genes 297
The isolates selected for genome sequencing display increased resistance to antifungal 298 drugs. Increased resistance to fluconazole is most commonly observed in C. auris with some 299 isolates also displaying increased resistance to voriconazole or amphotericin B (Table S1 ; 2 ).
300
The three related species all displayed increased amphotericin B resistance, and two were also 301 resistant to fluconazole. All isolates appeared sensitive to the echinocandins tested, 302 anidulafungin and caspofungin (Table S1). Most of the genes associated with drug resistance 303 and pathogenesis in C. albicans are conserved in C. auris, C. haemulonii, C. duobushaemulonii, 1 0 and C. pseudohaemulonii. We identified orthologs of genes noted to confer drug resistance in 305 C. albicans, either by acquiring point mutations, increasing transcription, or copy number 306 variation. The annotated genome assemblies of C. auris, C. haemulonii, C. duobushaemulonii, 307 and C. pseudohaemulonii contain a single copy of the ERG11 azole target and the UPC2 308 transcription factor that regulates expression of genes in the ergosterol pathway, as well as all 309 the gene components of the ergosterol biosynthesis pathway ( Table S5) Table S6 ). These two isolates also display increased resistance 326 to fluconazole (Table S1 ). Long read assemblies of these isolates could be used to examine the 327 chromosomal context of this duplication.
329
Additionally, we identified orthologs of transporters from the ATP binding cassette (ABC) and 
332
(CDR1 and CDR2) and the MFS transporter MDR1 31,32 . We identified a single copy of the 333 multidrug efflux pump MDR1 in all sequenced isolates ( Table 2) . We further characterized 334 presence of CDR genes and MDR1 in the C. auris population by examining CNV and gene 335 conservation across the 47 isolates from Lockhart et al. 2 , and did not detect any copy number 336 variation of these transporters across this set (Table S7 ). Candidate multidrug transporters 337 similar to CDR1, CDR2, and related genes include 5 genes in most genomes (C. auris B8441, 1 1 B11220, and B11243, C. haemulonii, and C. pseudohaemulonii), 6 genes in C. auris B11221, 339 and 4 genes in C. duobushaemulonii (Table 2; Figure S10 ). Phylogenetic analysis of these 340 ABC transporters showed that one of the genes in C. auris is related to CDR1/CDR2/CDR11, 341 two genes are related to CDR4, and two genes are related to SNQ2; C. auris B11221 has an 342 additional copy of SNQ2 (Figure S10) . The TAC1 transcription factor that regulates expression 343 of CDR1 and CDR2 in C. albicans is present in two tandem copies in C. auris, C. haemulonii, C.
344
duobushaemulonii, and C. pseudohaemulonii ( Table 2) 
356
auris and closely related species. We found a total of 75 genes with a predicted GPI anchor,
357
including genes that were found only in the emerging multidrug resistant clade, including one 358 unique family expanded in C. auris (Table S4 ). The most represented protein family domains in 359 these genes included the N-terminal cell wall domain, the aspartyl protease domain, and the 360 fungal specific cysteine rich (CFEM) domain ( Table S4 ). The shared profile of these genes 361 across C. auris and other MDR species suggests that the more rarely observed species may be 362 similarly primed to become more common human pathogens. 369 is resistant to AMB and exhibits an elevated MIC to VCZ, while B8441 is susceptible to AMB 370 and displays a low MIC to VCZ (Table S1; 2 ). We identified differentially expressed genes 371 (DEGs) in B8441 and B11210 after 2 and 4 hours of drug exposure (Methods; Table S9 ).
405
Since C. auris isolates B8441 and B11210 (clade I) had disparate resistance phenotypes 1 3 predominantly in response to AMB, we further examined expression changes between these 407 two strains. Despite the fact that B8441 and B11210 are from the same clade (clade I) only 8 408 genes were induced in both strains upon AMB treatment, including ARG1, CSA1 and MET15, 409 and one OPT1-like transporter (B9J08_001998) ( Table S10 ). In addition, comparison of both 410 isolates before treatment revealed that the resistant strain B11210 has higher expression of 411 genes previously noted to be involved in the C. albicans transcriptional response to drug 412 exposure relative to B8441 even in the absence of drug (Table S11) (Table S10 ). In addition, we observed that the expression levels of 417 homologs of multidrug transporters (CDR1, CDR4a, CDR4b, MDR1, SNQ2) did not significantly 418 vary across exposure to either drug or between isolates. Of these, CDR4a appears more highly 419 transcribed relative to other multidrug transporters (CDR1, MDR1 or SNQ2). This supports 420 previous findings of intrinsic higher expression of transporters as a possible mechanism of drug 421 resistance in C. auris 12 .
423
We compared these results to SNP variants identified between B8441 and B11210 to evaluate if 424 any may explain the phenotypic difference in drug resistance in these strains. We found a total 425 of 1,148 SNPs and 430 insertion or deletion events (Table S11). A total of 15 genes display a 426 loss of function mutation (frame-shift, stop gained or stop lost), including the stationary phase 427 protein (SNZ1) and the putative GPI-anchored adhesin-like protein (HYR3). We did not find loss 428 of function mutations in genes previously associated with amphotericin B resistance in C.
429
albicans, however, we did identify non-synonymous mutations in genes associated with drug 430 resistance and response to amphotericin B, including ERG11, ERG4, CDR1, C5_05230C_A,
431
NHP6A and other transporters such as HGT7 and YCF1, (Table S11). These variants suggest 432 candidate mutations that could explain phenotypic variation in drug resistance, however a wider 433 association study of mutations and drug resistance levels would help identify the major genes 434 involved across the different clades. and an aspartyl protease similar to SAP8 (Table S9 ). In addition, this set included gene families 444 that are expanded in C. auris or in closely related species (Figures 3b and 4) , including 445 transporters (four SIT-like, one FTR-like, and two OPT-like class), cell wall adhesins, and 446 several predicted secreted proteins (Table S9) . Notably, while other Saccharomycetales 447 species including C. albicans only have one copy of SIT1 that is induced during AMB treatment,
448
C. auris and closely related species had up to 11 SIT1-like genes, of which 4 are induced during 449 AMB treatment (Figures 3b, 4, S6) . Together, these transcriptional changes highlighted shared 
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To characterize mechanisms that may contribute to virulence and drug resistance, we 473 compared the gene content between the emerging multidrug resistant species and other related 1 1 6 described C. auris clades consists of isolates that are all MTLa or MTLα; as the clades are 509 geographically restricted, this suggests that there is a geographic barrier to opposite sex mating.
510
This expectation would change if wider sampling demonstrated the establishment of both 511 mating types within a geographic area. The potential for mating within this species is supported 512 by the conservation of genes involved in mating and meiosis; these patterns are similar to that 513 of the related species C. lusitaniae, for which mating and recombination have been 514 demonstrated 24 . Isolates from clades of opposite mating types could be directly tested for 515 mating and production of progeny. One potential barrier to mating between clades is the 516 presence of chromosomal rearrangements, as some recombination events may result in 517 inviable progeny.
519
Analyses of these genomes have revealed fundamental aspects of these emerging multidrug 520 resistant fungi. The role of specific genes in mating, drug resistance or pathogenesis needs to 521 be directly tested, utilizing gene deletion technologies recently adapted for C. auris (e.g. 38 ).
522
Further analysis of this data will not only advance our understanding of the basis of drug 523 resistance and virulence of this pathogen but can also inform development of fungal diagnostics 524 for accurate tracking of these emerging pathogens. Strains used in this study were described previously 2,18,19 ; brief details are presented in 530 
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To measure nucleotide diversity we used SNPs identified from the isolate sequences of 
732
II, III and IV) and mating type (MTLa and MTLα). Figure S3 
